Viagra
Product Images NDC 21695-157

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Viagra (NDC 21695-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Chemical Structure (4d60822d 1c9b 494d Adb3 20fe921d9c58 01)

Chemical structure of the active ingredient in Viagra, showing its molecular arrangement including multiple rings, nitrogen atoms, and functional groups such as sulfonamide and carboxylate moieties.*

FDA Label Image

Image Of Figure 1 (mean Sildenafil Plasma Concentrations) (4d60822d 1c9b 494d Adb3 20fe921d9c58 02)

A pharmacokinetic curve showing plasma concentrations (ng/ml) of a drug labeled as 'Commercial Tablet' over time in hours post-dose for up to 24 hours. The graph illustrates concentration levels peaking between 0 and 2 hours, then gradually declining over the remaining time.*

FDA Label Image

Image Of Figure 2 (mean Change From Baseline) (4d60822d 1c9b 494d Adb3 20fe921d9c58 03)

A line graph comparing systolic blood pressure changes (mmHg) over 24 hours after dosing of Sildenafil 100 mg versus placebo. The x-axis represents time post dose in hours, including a pre-dose baseline, and the y-axis indicates systolic blood pressure change in mmHg.*

FDA Label Image

Image Of Figure 3 (effect Of Viagra And Placebo) (4d60822d 1c9b 494d Adb3 20fe921d9c58 04)

A bar chart titled 'Effect of Placebo on Maintenance of Erection by Baseline Score' showing the percentage of patients at endpoint across baseline scores 0 through 5. Each score category includes multiple bars representing different scores from 0 to 5, with varying heights indicating the distribution percentages.*

FDA Label Image

Image Of Figure 4 (percentage Of Patients Reporting) (4d60822d 1c9b 494d Adb3 20fe921d9c58 05)

A bar chart comparing the percentage of patients reporting improvement across four treatment groups: Placebo, and Viagra 25 mg, 50 mg, and 100 mg doses. The chart shows increasing improvement rates with higher Viagra doses, with values ranging from 24% for placebo to 82% for the highest dose. The overall treatment is noted as statistically significant with p<0.0001.*

FDA Label Image

Image Of Figure 5 (mean Standing Systolic Blood Pressure) (4d60822d 1c9b 494d Adb3 20fe921d9c58 06)

A line graph showing the change in systolic blood pressure (SBP) over time postdose (hours) comparing Doxazosin with placebo and Doxazosin with Sildenafil 25 mg. The y-axis represents the change in SBP (mmHg) and the x-axis represents time postdose in hours, with data points plotted for up to 8 hours.*

FDA Label Image

Image Of Figure 6 (mean Standing Systolic Blood Pressure) (4d60822d 1c9b 494d Adb3 20fe921d9c58 07)

A line graph showing the change in systolic blood pressure (SBP) in mmHg over time postdose (hours). It compares two treatments: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg, with data points connected by lines and a legend identifying each treatment group.*

FDA Label Image

Image Of Figure 7 (mean Standing Systolic Blood Pressure) (4d60822d 1c9b 494d Adb3 20fe921d9c58 08)

A line graph showing the effect over time of Doxazosin combined with Sildenafil 100 mg versus Doxazosin combined with Placebo. The x-axis is labeled Time After Dosing (hr), and the y-axis indicates changes in mmHg, ranging from -50 to 40. Two lines represent the two treatment groups, with Sildenafil showing lower values throughout most of the 8-hour period compared to Placebo.*

FDA Label Image

Image Of Pfizer Logo (4d60822d 1c9b 494d Adb3 20fe921d9c58 09)

FDA Label Image

Image Of Word Viagra (4d60822d 1c9b 494d Adb3 20fe921d9c58 10)

The image shows a label for Viagra tablets featuring the brand name 'VIAGRA' prominently in bold black uppercase letters. Below the brand name, the active ingredient 'sildenafil citrate' is listed in parentheses in italics, followed by the word 'tablets' indicating the dosage form. The label reflects a product of Rebel Distributors Corp.*

FDA Label Image

Image Of Pfizer Logo (4d60822d 1c9b 494d Adb3 20fe921d9c58 11)

FDA Label Image

Viagra 50 mg (4d60822d 1c9b 494d Adb3 20fe921d9c58 12)

Viagra 50mg tablets packaging label from Physician Partner with NDC 21695-157-30. The label indicates the product contains 30 tablets with each tablet containing Sildenafil citrate equivalent to Sildenafil 50mg. It also notes manufacturer information for Pfizer Labs and storage instructions.*

FDA Label Image

Viagra 100 mg (4d60822d 1c9b 494d Adb3 20fe921d9c58 13)

Packaging label for Viagra 100 mg tablets by Rebel Distributors Corp. The label indicates a quantity of 30 tablets, each containing sildenafil citrate. It shows the NDC number 21695-158-30 and mentions distribution by Physician Partner, Thousand Oaks, CA. The label includes storage instructions and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.